Good Steward Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,004
Closed -$229K 69
2025
Q4
$229K Sell
1,004
-423
-30% -$96.4K 0.15% 66
2025
Q3
$330K Sell
1,427
-727
-34% -$148K 0.23% 51
2025
Q2
$400K Sell
2,154
-1,932
-47% -$359K 0.31% 49
2025
Q1
$856K Buy
+4,086
New +$794K 0.78% 31

Other funds holding ABBV

Good Steward Wealth Advisors's ABBV Position: Q1 2026 in Review

Good Steward Wealth Advisors sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,004 shares — an estimated $229K sold.

Good Steward Wealth Advisors first reported a position in ABBV in Q1 2025 and held it in 4 quarters. The position peaked at $856K in Q1 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Good Steward Wealth Advisors reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Good Steward Wealth Advisors sold 1,004 AbbVie shares in Q1 2026, an estimated $229K.
  • Good Steward Wealth Advisors first reported a position in AbbVie in Q1 2025 and held it in 4 quarters.
  • Good Steward Wealth Advisors's AbbVie position peaked at $856K in Q1 2025.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Good Steward Wealth Advisors's 13F filing for Q1 2026, filed 4 May 2026.